European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company’s Oritavancin
[Marketwired] – The Medicines Company today announced that the European Medicines Agency has accepted for review a marketing authorization application for the investigational intravenous antibiotic, oritavancin, for the … more
View todays social media effects on MDCO
View the latest stocks trending across Twitter. Click to view dashboard
See who The is hiring next, click here to view
